Global Blood Therapeutics, Inc.

NasdaqGS:GBT 株式レポート

時価総額:US$4.6b

Global Blood Therapeutics 過去の業績

過去 基準チェック /06

Global Blood Therapeuticsの収益は年間平均-20.1%の割合で減少していますが、 Biotechs業界の収益は年間 増加しています。収益は年間19% 74.8%割合で 増加しています。

主要情報

-20.1%

収益成長率

-12.1%

EPS成長率

Biotechs 業界の成長17.0%
収益成長率74.8%
株主資本利益率-272.4%
ネット・マージン-137.3%
前回の決算情報30 Jun 2022

最近の業績更新

Recent updates

Global Blood Therapeutics expects to complete Pfizer deal in early October

Sep 30

Global Blood Therapeutics: Pfizer Acquisition Signals Increasing M/A Deals

Sep 16

Pfizer said to have had bidding war with Johnson & Johnson for Global Blood

Aug 24

What Pfizer Is Getting Through The Acquisition Of Global Blood Therapeutics

Aug 08

Global Blood Therapeutics to expand access to its sickle cell disease treatment in Brazil

Jul 14

GBT begins phase 2/3 clinical trial of GBT601 to treat sickle cell disease

Jun 29

Global Blood Therapeutics: Powerhouse Of The Future

Jun 21

Global Blood Therapeutics (NASDAQ:GBT) Is Making Moderate Use Of Debt

Jun 07
Global Blood Therapeutics (NASDAQ:GBT) Is Making Moderate Use Of Debt

Global Blood Therapeutics: Hitting A Growth Inflection

Apr 12

Global Blood Therapeutics: Changing My Strategy After Recent Earnings

Mar 12

Is Global Blood Therapeutics (NASDAQ:GBT) Using Too Much Debt?

Feb 24
Is Global Blood Therapeutics (NASDAQ:GBT) Using Too Much Debt?

Global Blood Therapeutics: Revisiting A Stellar Grower

Dec 25

IBI Research On Global Blood Therapeutics: Galvanized For Growth

Nov 30

Despite Lacking Profits Global Blood Therapeutics (NASDAQ:GBT) Seems To Be On Top Of Its Debt

Nov 03
Despite Lacking Profits Global Blood Therapeutics (NASDAQ:GBT) Seems To Be On Top Of Its Debt

Global Blood Therapeutics: It Might Be Time To Buy The Dip

Oct 24

Global Blood Therapeutics: Attempting To Classify The Investment

Aug 07

Global Blood Therapeutics (NASDAQ:GBT) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Jul 08
Global Blood Therapeutics (NASDAQ:GBT) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Shareholders May Not Be So Generous With Global Blood Therapeutics, Inc.'s (NASDAQ:GBT) CEO Compensation And Here's Why

Jun 12
Shareholders May Not Be So Generous With Global Blood Therapeutics, Inc.'s (NASDAQ:GBT) CEO Compensation And Here's Why

Global Blood Therapeutics announces employment inducement grants

Jun 04

Global Blood Therapeutics: Increasing Specialization In SCD

May 09

Is Global Blood Therapeutics (NASDAQ:GBT) A Risky Investment?

Mar 18
Is Global Blood Therapeutics (NASDAQ:GBT) A Risky Investment?

Breakeven On The Horizon For Global Blood Therapeutics, Inc. (NASDAQ:GBT)

Feb 20
Breakeven On The Horizon For Global Blood Therapeutics, Inc. (NASDAQ:GBT)

Did Business Growth Power Global Blood Therapeutics' (NASDAQ:GBT) Share Price Gain of 152%?

Jan 25
Did Business Growth Power Global Blood Therapeutics' (NASDAQ:GBT) Share Price Gain of 152%?

Have Insiders Been Buying Global Blood Therapeutics, Inc. (NASDAQ:GBT) Shares?

Dec 29
Have Insiders Been Buying Global Blood Therapeutics, Inc. (NASDAQ:GBT) Shares?

収支内訳

Global Blood Therapeutics の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqGS:GBT 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 22235-322303227
31 Mar 22211-310283214
31 Dec 21195-303267212
30 Sep 21180-277248194
30 Jun 21165-266234184
31 Mar 21149-249222166
31 Dec 20124-248211155
30 Sep 2085-282196179
30 Jun 2048-286171178
31 Mar 2016-291147180
31 Dec 192-267117175
30 Sep 190-22088146
30 Jun 190-19971140
31 Mar 190-18257136
31 Dec 180-17451131
30 Sep 180-16646127
30 Jun 180-15243114
31 Mar 180-13538100
31 Dec 170-1173188
30 Sep 170-1032776
30 Jun 170-952472
31 Mar 170-892266
31 Dec 160-822061
30 Sep 160-712052
30 Jun 160-651649
31 Mar 160-581343

質の高い収益: GBTは現在利益が出ていません。

利益率の向上: GBTは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: GBTは利益が出ておらず、過去 5 年間で損失は年間20.1%の割合で増加しています。

成長の加速: GBTの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: GBTは利益が出ていないため、過去 1 年間の収益成長をBiotechs業界 ( -2.3% ) と比較することは困難です。


株主資本利益率

高いROE: GBTは現在利益が出ていないため、自己資本利益率 ( -272.44% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘